HY-133011-1mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-10mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-25mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-5mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-50mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-1mL
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0380-10mg
|
MedChemexpress LLC
|
Nardosinone [CAS 23720-80-1]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0380-20mg
|
MedChemexpress LLC
|
Nardosinone [CAS 23720-80-1]
|
|
Neuroscience-Neurodegeneration
|
|
HY-N0380-5mg
|
MedChemexpress LLC
|
Nardosinone [CAS 23720-80-1]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-10mg
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-100mg
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-25mg
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-5mg
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-50mg
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-144776-1mL
|
MedChemexpress LLC
|
NAT [CAS 831243-31-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-126429-10mg
|
MedChemexpress LLC
|
Nav1.1 activator 1 [CAS 2332897-85-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-126429-100mg
|
MedChemexpress LLC
|
Nav1.1 activator 1 [CAS 2332897-85-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-126429-5mg
|
MedChemexpress LLC
|
Nav1.1 activator 1 [CAS 2332897-85-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-126429-50mg
|
MedChemexpress LLC
|
Nav1.1 activator 1 [CAS 2332897-85-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-126429-1mL
|
MedChemexpress LLC
|
Nav1.1 activator 1 [CAS 2332897-85-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-108237-10mg
|
MedChemexpress LLC
|
Naxagolide [CAS 88058-88-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-108237-100mg
|
MedChemexpress LLC
|
Naxagolide [CAS 88058-88-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-108237-25mg
|
MedChemexpress LLC
|
Naxagolide [CAS 88058-88-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-108237-5mg
|
MedChemexpress LLC
|
Naxagolide [CAS 88058-88-2]
|
|
Neuroscience-Neurodegeneration
|
|
HY-108237-50mg
|
MedChemexpress LLC
|
Naxagolide [CAS 88058-88-2]
|
|
Neuroscience-Neurodegeneration
|
|